Norethindrone Medicare Part D Coverage: What Women Need to Know in 2026

What Is Norethindrone and Why Do Women Take It?

Norethindrone is a synthetic progestin used across nearly every stage of a woman's reproductive life. You may know it as the "mini-pill" (Camila, Errin, Heather, Jencycla, Nora-BE), a component of combination oral contraceptives, or as norethindrone acetate (Aygestin) for non-contraceptive indications.

The conditions it treats read like a map of female-specific hormonal health:

• Contraception (progestin-only pill)
• Abnormal uterine bleeding secondary to hormonal imbalance
• Secondary amenorrhea
• Endometriosis pain management
• PCOS cycle regulation and androgen suppression
• Perimenopause cycle irregularity and heavy bleeding
• Postmenopausal hormone therapy (in combination with estrogen, to protect the uterine lining)

Because norethindrone serves so many clinical purposes across the life span, its coverage under Medicare Part D is not a simple yes or no. The answer depends on your specific diagnosis, your plan's formulary, and the diagnosis code your prescriber submits.

How Norethindrone Works

Norethindrone binds to progesterone receptors in the uterus, ovaries, and hypothalamus. In contraceptive doses (0.35 mg daily), it thickens cervical mucus and suppresses ovulation inconsistently. In higher doses used for endometriosis or abnormal bleeding (2.5 mg to 10 mg daily as norethindrone acetate), it induces a pseudodecidual response in endometrial tissue, reducing abnormal proliferation. The progestin-only pill's mechanisms are reviewed in the ACOG Practice Bulletin on contraception.

Sex-specific pharmacokinetics matter here. Norethindrone's bioavailability after oral administration is approximately 64% in women, with significant first-pass hepatic metabolism. Body weight and body composition, which differ between women and men, influence distribution volume. In women with obesity (BMI >30), some evidence suggests reduced contraceptive efficacy at the standard 0.35 mg dose, though the data remain limited and guidelines have not yet changed dosing recommendations on this basis. A 2021 analysis in Contraception found that while progestin levels were lower in women with higher BMI, cervical mucus thickening appeared maintained.

Does Medicare Part D Cover Norethindrone?

The short answer: usually not for contraception, and it depends on your plan for other indications.

The Federal Contraceptive Exclusion

Medicare Part D plans are prohibited from covering outpatient prescription drugs used for contraception under 42 U.S.C. § 1395w-102(e)(2), which lists contraceptives among the categories excluded from standard Part D benefit design. The Centers for Medicare and Medicaid Services confirms this exclusion in its Part D benefit parameters guidance.

This means: if your prescriber writes a norethindrone prescription with a contraceptive diagnosis code (Z30.019 for encounter for initial prescription of contraceptive), your Part D plan will almost certainly reject it at the pharmacy counter.

Non-Contraceptive Coverage: A Different Story

If norethindrone is prescribed for endometriosis (N80.x), abnormal uterine bleeding (N93.x), secondary amenorrhea (N91.1), or as part of postmenopausal hormone therapy, some Part D plans place it on their formulary. Coverage varies dramatically by plan. A 2023 formulary analysis found that fewer than 30% of Part D plans covered norethindrone acetate (Aygestin) in any tier, and those that did often placed it on Tier 3 (preferred brand) or Tier 4 (non-preferred), with copays ranging from $47 to $100+ per fill.

What to Do Before You Fill

1. Call the Member Services number on your Part D card and ask specifically: "Is norethindrone acetate covered for diagnosis code N80.1 (endometriosis of the uterus) under my formulary?"
2. Ask your prescriber to submit a prior authorization with the clinical diagnosis, not a contraceptive indication, if that is medically accurate.
3. Check your plan's Evidence of Coverage document (available at Medicare.gov Plan Finder).
4. If denied, request a formulary exception. Your prescriber can submit a letter of medical necessity.

This four-step verification framework, applied before every fill, is the single most effective way to avoid an unexpected $100+ charge at the pharmacy counter.

Life Stage Guide: Who Is on Medicare and Taking Norethindrone?

Most women on Medicare are 65 or older, or are under 65 with a qualifying disability. Here is how norethindrone use looks across the relevant life stages for this population.

Perimenopause (Typically Ages 45-55)

Some women enter Medicare before menopause due to disability. During perimenopause, estrogen fluctuates wildly and progesterone production becomes erratic. Norethindrone acetate (2.5 mg to 5 mg daily) is sometimes prescribed to stabilize cycles, reduce heavy bleeding, and prevent endometrial hyperplasia in women using estrogen therapy. The Menopause Society (formerly NAMS) 2022 Hormone Therapy Position Statement supports the use of progestogens to protect the endometrium in women with a uterus who are using systemic estrogen.

If you are in perimenopause and on Medicare due to disability, the non-contraceptive diagnosis code is your strongest argument for Part D coverage.

Postmenopause

In postmenopause, norethindrone acetate is used as the progestogen component of hormone therapy in women who have a uterus. The Women's Health Initiative trial arm using conjugated equine estrogen plus medroxyprogesterone acetate (not norethindrone, but a closely related progestin) showed a 26% increased risk of breast cancer compared to placebo, which raised questions applicable to all synthetic progestins. Norethindrone acetate has not been studied in a dedicated large randomized trial of this scale, and extrapolating WHI data to norethindrone carries uncertainty. This is a genuine evidence gap you deserve to know about.

The Menopause Society notes that the risk-benefit balance for hormone therapy is highly individual and depends on age, time since menopause, symptom burden, and cardiovascular and breast risk profile.

Women Under 65 on Medicare Due to Disability

You may be in your 30s or 40s, still in your reproductive years, and using norethindrone for PCOS, endometriosis, or contraception. The contraceptive exclusion still applies. For PCOS cycle regulation or endometriosis, work with your prescriber to ensure the diagnosis code reflects the clinical indication, not contraception.

Pregnancy, Lactation, and Contraception: What Every Woman Must Know

Norethindrone is contraindicated in pregnancy. This is not a soft caution. It belongs to FDA Pregnancy Category X for its use in contraception and hormonal indications, meaning animal and human data show fetal risk that outweighs any benefit. The FDA prescribing information for norethindrone acetate (Aygestin) states explicitly that the drug is contraindicated in women who are or may become pregnant.

What the Data Show

Norethindrone has androgenic properties. Exposure during the first trimester has been associated with virilization of female fetuses, including clitoral enlargement and labial fusion, in case reports. The absolute risk appears low, but no safe dose in pregnancy has been established. If you are prescribed norethindrone for a non-contraceptive reason and you are in your reproductive years, your prescriber should confirm that you are not pregnant and discuss reliable contraception.

Lactation

Norethindrone does transfer into breast milk. A review in the journal Contraception found that infant exposure through milk is low, approximately 0.1% of the maternal dose. The progestin-only pill is one of the few hormonal methods considered compatible with breastfeeding by the World Health Organization and ACOG Practice Bulletin 206. However, timing matters: progestin-only pills are typically started at six weeks postpartum to avoid any theoretical impact on milk supply establishment in the first month.

Contraception Requirement

Women taking norethindrone acetate at higher doses for endometriosis or abnormal bleeding who are also in their reproductive years should use a reliable non-hormonal contraceptive method (such as a copper IUD) if they wish to avoid pregnancy, since the hormonal dose and formulation differ from the contraceptive mini-pill and efficacy for pregnancy prevention at those doses is not established in the same way.

How to Get Norethindrone Cheaply: Real Options in 2026

Cash Pay: The Baseline

The average cash price for a 30-day supply of norethindrone 0.35 mg is approximately $20 at large retail chains (CVS, Walgreens, Walmart). Norethindrone acetate 5 mg (Aygestin or generic) averages slightly higher, around $25-$45 depending on quantity and location. These are already low costs, which is why for many women, fighting for Part D coverage yields less savings than simply using a discount program.

GoodRx and Similar Discount Cards

GoodRx, RxSaver, and similar platforms negotiate rates with pharmacies and can bring norethindrone costs to $10-$18 at many locations. These programs are available to anyone regardless of insurance status. GoodRx is not insurance, and using it means your fill does not count toward your Part D deductible or out-of-pocket maximum, so weigh that tradeoff if you have other expensive medications.

Medicare Extra Help (Low Income Subsidy)

If your income and assets fall below certain thresholds, the Extra Help program (also called the Low Income Subsidy) can reduce your Part D copays to $0 to $11 per fill. As of 2026, the income threshold is approximately 150% of the federal poverty level. Apply through the Social Security Administration at ssa.gov/medicare/part-d-extra-help or through your State Health Insurance Assistance Program (SHIP).

State Pharmaceutical Assistance Programs

Over 30 states run pharmaceutical assistance programs for low-income Medicare beneficiaries. The Medicare Rights Center maintains a state-by-state directory. These programs can cover copays or wrap around Part D gaps.

Manufacturer and Generic Coupons

Because norethindrone is available as a generic from multiple manufacturers (Teva, Aurobindo, Northstar), there is no single brand manufacturer coupon program the way there is for a branded drug like Aygestin. Generic norethindrone acetate tabs from Teva occasionally have copay cards through specialty pharmacy networks, but these are not consistently available and are rarely needed given the low cash price.

Title X Family Planning Clinics

If you are under 65 and on Medicare due to disability, and you need norethindrone specifically for contraception, Title X-funded family planning clinics provide contraceptive services on a sliding-fee scale, sometimes at no cost, regardless of insurance status. Use the clinic locator at HHS.gov.

Insurance Coverage Beyond Medicare: Private Plans and Medicaid

ACA-Compliant Private Plans

Under the Affordable Care Act, most private insurance plans are required to cover FDA-approved contraceptive methods, including progestin-only pills, at no cost sharing. The HRSA contraceptive coverage mandate specifies that at least one form of each contraceptive category must be covered without cost. If your plan covers a brand and not your generic (or vice versa), request an exception.

Medicaid

Medicaid covers norethindrone for contraceptive and non-contraceptive indications in most states with little to no cost sharing. If you became Medicare-eligible through disability and you also have low income, you may qualify for dual Medicare-Medicaid eligibility (duals), which can fill coverage gaps. Contact your state Medicaid office or SHIP counselor.

Employer-Sponsored Insurance

Most employer plans subject to ACA rules must cover the progestin-only pill with no cost sharing under the contraceptive mandate. The norethindrone acetate formulations used for non-contraceptive purposes (Aygestin) may require a prior authorization under most formularies.

Who This Is Right For, and Who Should Pause

Norethindrone is a well-tolerated progestin for most women, but it is not the right choice in every situation.

Women Who Generally Benefit

• Perimenopause with a uterus using estrogen therapy: needs a progestogen for endometrial protection; norethindrone acetate is a guideline-supported option
• PCOS with irregular cycles: low-dose cyclic norethindrone or the progestin-only pill can regulate cycles and reduce androgen-driven symptoms
• Endometriosis: higher-dose norethindrone acetate (5 mg daily, sometimes titrated to 10-15 mg) has a meaningful evidence base for pain reduction; a 2018 study in the Journal of Minimally Invasive Gynecology found that 75% of women with endometriosis-associated pain had significant relief on norethindrone acetate 5 mg at 12 months
• Women seeking low-cost contraception without estrogen: those with migraines with aura, cardiovascular risk factors, or breastfeeding needs who cannot use combined pills

Women Who Should Discuss Alternatives

• Active or history of breast cancer: synthetic progestins are generally avoided; discuss with your oncologist
• Unexplained vaginal bleeding: requires evaluation before starting any progestogen
• Severe liver disease: norethindrone is hepatically metabolized; dose adjustment may be needed
• Women with depression history: some women report mood changes on progestin-only methods; data are limited but real; a 2016 Danish cohort study in JAMA Psychiatry found hormonal contraceptives as a class were associated with increased antidepressant use, with the progestin-only pill carrying an adjusted relative risk of 1.34
• Pregnancy (any trimester): absolutely contraindicated, as described above

Talking to Your Prescriber: Questions That Help With Coverage

Getting the right diagnosis code on your prescription is not gaming the system. It is accurate documentation of why you are taking the drug. Here are questions to ask:

• "Is my primary clinical indication for norethindrone a non-contraceptive diagnosis that could be submitted on the prescription?"
• "Can you write a letter of medical necessity if my Part D plan requires prior authorization?"
• "Is norethindrone acetate (Aygestin) or norethindrone 0.35 mg the better formulation for my specific condition, and does that affect coverage?"
• "Should we try GoodRx first given the low cash price, or is it worth pursuing the Part D appeal?"

As WomanRx reviewer Rachel Goldberg, MD, puts it: "For most of my Medicare patients who need norethindrone for endometrial protection or endometriosis management, the cash price at Walmart or Costco is $15 to $20, and the time cost of a Part D prior authorization appeal often exceeds the financial benefit. I tell patients: file the appeal if you want the principle recorded, but fill the prescription with GoodRx while you wait."

Navigating the Annual Part D Formulary Change

Medicare Part D formularies reset every January 1. A plan that covered norethindrone acetate in 2025 may remove it from the formulary in 2026. You should:

1. Review your Annual Notice of Change (ANOC) letter each fall, which your plan sends before October 15.
2. Use the Medicare Plan Finder during Open Enrollment (October 15 to December 7) to compare formulary coverage for your specific medications.
3. Ask your pharmacist to run a coverage check at your first January fill each year.

If your plan drops norethindrone from formulary and you have a qualifying condition, you have the right to request a formulary exception within the first 60 days of the plan year.

Conditions Particularly Relevant to Women Taking Norethindrone on Medicare

Osteoporosis

Women in postmenopause are at elevated fracture risk. Long-term use of norethindrone at high doses (as used for endometriosis suppression) has raised theoretical concerns about bone density because it may partially suppress estrogen. The Endocrine Society's clinical practice guideline on osteoporosis notes that combination hormone therapy with estrogen plus progestogen generally maintains or improves bone mineral density, so the net effect in the postmenopausal context is typically protective when estrogen is co-administered.

Female Pattern Hair Loss

Norethindrone's mild androgenic activity is relevant here. Unlike progesterone or dydrogesterone (not available in the US), norethindrone acetate has androgenic properties that could theoretically worsen androgenic alopecia in susceptible women. If you have female pattern hair loss and are being prescribed norethindrone, ask your provider whether a less androgenic progestogen (micronized progesterone, for example) is an option for your indication.

Cardiovascular Health

Synthetic progestins including norethindrone may attenuate some of estrogen's favorable effects on lipid profiles. A review in Climacteric found that norethindrone acetate combined with estradiol produced a neutral to slightly adverse effect on HDL compared to micronized progesterone combinations. This matters for postmenopausal women with existing cardiovascular risk factors. Ask your prescriber to review your full lipid panel before and six months after starting.